Abstract
The treatment by Western countries of bleeding from esophageal varices was reviewed from three definite viewpoints; prevention of first bleeding or prophylactic treatment, control of acute bleeding or emergency treatment, and prevention of rebleeding or elective treatment. Even though prophylactic surgery has been abandoned on the basis of several randomized studies, some authors still perform esophageal transection and report encouraging results. In emergency situations, the role of surgery has been limited by the prohibitive hospital mortality and by the introduction of vasoactive drugs and endoscopic sclerotherapy. Nevertheless, good immediate and long term results have been obtained in specialized centers in which bleeding patients undergo surgery no later than 8 hours after their admission. As regards the prevention of rebleeding, non selective portal decompression gives adequate protection against rebleeding, however, hepatoencephalopathy follows in considerable incidence. In order to avoid this complication, direct operations on varices have been performed, largely with good results. The Warren shunt offers results showing advantage over the non-selective shunt in the first postoperative period but later on, it behaves hemodynamically as a total shunt and the advantage is then cancelled. We report herein a review of the literature and also describe our personal experience with treating bleeding esophageal varices.
Similar content being viewed by others
References
Pagliaro L, D'Amico G, Maringhini A, Fantauzzo B, Pasta L, Palazzo U, Gatto G, Orsini S. History of non-alcoholic cirrhosis. In: Medical and surgical problems of portal hypertension. Orloff MJ, Stipa S, Ziparo V, eds. London: Academic Press, 1980; 109–117.
Burroughs AK, D'Heygere F, McIntyre N. Pitfalls in studies of prophylactic therapy for variceal bleeding in cirrhotics. Hepatology 1986; 6: 1407–1413.
De Franchis R, the North-Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Endoscopic markers; a Multicenter Prospective Study. In: Proceeding of Portal Hypertension in Cirrhosis: Current Prospective of Treatment (AISF) 1985; 15.
Jackson FC, Perrin EB, Smith AG, Dagradi AE, Nadal HM. Survival analysis of the prophylactic operation. Am J Surg 1968; 115: 22–42.
Resnick RH, Chalmers TC, Ishihara AM, Garceau AJ, Callow AD, Schimmel EM, O'Hara ET, the Boston Inter-Hospital Liver Group. A controlled study of the prophylactic portacaval shunt. A final report. Ann Inter Med 1969; 70: 675–688.
Conn HO, Lindenmuth WW, May CJ, Ramsby GR. Prophylactic portacaval anastomosis. A tale of two studies. Medicine 1972; 51: 27–40.
Inokuchi K, Cooperative Study Group of Portal Hypertension of Japan. Prophylactic portal nondecompression surgery in patients with esophageal varices. Ann Surg 1984; 200: 61–65.
Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices. A prospective controlled randomized trial. Endoscopy 1982; 14: 4–5.
Witzel L, Wolbergs E, Merki H. Prophylactic endoscopic sclerotherapy of oesophageal varices. Lancet 1985; i: 773–775.
Sauerbruch T, Wotzka R, Kopcke W, Harlin M, Kuhner W, Sander R, Heldwein B, Ansari H, Paumgartner G. Endoscopic sclerotherapy for prophylaxis of variceal bleeding in liver cirrhosis. A multicentric controlled trials. In: Proceedings of International Symposium on Prophilaxis of Variceal Bleeding. Munich, 1986.
Fleig WE, Stange EF, Wordehoff D, Rainer K, Ditschumeit H. Endoscopic sclerotherapy for the primary prophylaxis of variceal bleeding in cirrhotic patients. Preliminary results of a randomized controlled trial. In: Proceedings of International Symposium on Prophylaxis of Variceal Bleeding. Munich, 1986.
Koch H, Henning H, Grimm H, Soehendra N. Prophylactic sclerosing of esophageal varices. Results of a prospective controlled study. Endoscopy 1986; 40–43.
Piai G, Cipolletta L, Claar M, Marone G, Bianco MA. A prospective controlled randomized study of prophylactic sclerotherapy of oesophageal varices prior to first haemorrhage. In: Proceeding of Portal Hypertension in Cirrhosis: Current Perspectives of Treatment (AISF) 1985; 72.
Gregory C. Prophylactic sclerotherapy for variceal bleeding: preliminary results of a controlled clinical USA. Digestive Disease Week, Chicago, May 9–15, 1987 (Abs).
Cales P, Pascal JP, a Multicenter Study Group, Controlled trial of Propranolol in the prevention of first variceal bleeding in cirrhotic patients. USA Digestive Disease Week, S. Francisco, May 12–21, 1986 (Abs 780, P. A195).
The Italian Multicentre Project for Propranolol in Prevention of Bleeding. Beneficial effect of Propranolol in prevention of first bleeding in cirrhosis without ascites. Final results of a multicentre trial. Dig Dis and Sci, 1986, Suppl. Abs 511, p. 130S.
Lebrec D, Poynard T, Capron JP. A randomized trial of nadolol for prevention of gastrointestinal bleeding in patients with cirrhosis. Results at one year. USA Digestive Disease Week, S. Francisco, May 12–21, 1986 (Abs).
Beppu K, Inokuchi K, Koyanagi N. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27.
The Italian Liver Cirrhosis Project. Reliability of endoscopy in the assessment of variceal features. J Hepatol 1987; 4: 93.
Graham DY, Smith JL. The course of patients after variceal haemorrhage. Gastroenterology 1981; 80: 800–809.
De Dombal FT, Clarke JR, Clamp SE, Malizia G, Kotwal MR, Morgan AG. Prognostic factors in upper GI bleeding. Endoscopy 1986; 18 (suppl 2): 6–10.
Thomas E, Rosenthal WS, Rymer W, Katz D. Upper gastrointestinal hemorrhage in patients with alcoholic liver disease and esophageal varices. Am J Gastroent 1979; 72: 623–629.
Smith JL, Graham DY. Variceal haemorrhage, a critical evaluation of survival analysis. Gastroenterology 1982; 82: 968–972.
Merigan TC, Poltkin GR, Davidson CS. Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding esophageal varices. N Engl J Med 1962; 266: 134–135.
Fogel MR, Knauer M, Andres LL, Mahal AS, Stein DE, Kemeny MJ, Rinky MM, Walker JE, Sigmund D, Gregory PB. Continuous intravenous vasopressin in active upper gastrointestinal bleeding. A placebo controlled trial. Ann Intern Med 1982; 96: 565–569.
Conn HO, Ramsby GR, Storer EH, Mutchnick MG, Josai PH, Phillips MM, Cohen GA, Fields BN, Petroski D. Intra-arterial vasopressin in the treatment of upper gastrointestinal haemorrhage: a prospective controlled clinical trial. Gastroenterology 1975; 68: 211–221.
Freeman JG, Lishman AH, Cobden I, Record CO. Controlled trial of terlipressin (glypressin)versus vasopressin in the early treatment of oesofhageal varices. Lancet 1982; 2: 66–68.
Freeman JG, Cobden I, Record CO. Placebo controlled trial of glypressiin in the management of acute variceal bleeding. Gut 1986; 27: A1247 (abstract).
Walker S, Stiehl A, Raedsch R, Kommerell B. Terlipressin in bleeding oesophageal varices: a placebo controlled, double blind study. Hepatology 1986; 6: 112–115.
Kravetz D, Bosch J, Teres J, Bruix J, Rimola A, Rodes J. Comparison of intravenous somatostatin and vasopressin infusions in the treatment of acute variceal haemorrhage. Hepatology 1984; 4: 422–446.
Jenkins SA, Baxter JN, Corbett WA, Devitt P, Ware J, Shields R. A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J 1985; 290: 1275–1278.
Tsai Y-T, Lay C-S, Lai K-H, Ng W-W, Yen Y-S, Wang JY, Chiang T-T, Lee S-D, Chiang BN, Lo W-J. Controlled trial of vasopressin plus nitroglycerin vs vasopressin alone in the treamtent of bleeding oesophageal varices. varices. Hepathology 1986; 6: 406–409.
Gimson AES, Westaby D, Hegarty J, Watson A, Williams R. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal haemorrhage. Hepatology 1986; 6: 410–431.
Pinto Correia J, Martin Alves M, Alexandrino P, Silveira J. Controlled trial of vasopressin and balloon tamponade in bleeding oesophageal varices. Hepatology 1984; 4: 885–888.
Clanet R, Tournut R, Foutanier G, Joncquiert F, Pascal JP. Traitement par la pitressine des hemorragies rupture de varices oesophagiennes chez le cirrhotique. Etude controllee. Acta Gastroent Belg 1978; 41: 539–543.
Teres J, Cecilia A, Bordas JM, Rimola A, Bru G, Rodes J. Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 1978; 75: 566–569.
Mitchell K, Silk DA, Williams R. Prospective comparison of two Sengstaken tubes in the management of patients with variceal haemorrhage. Gut 1980; 21: 570–573.
Orloff MJ, Bell RH, Greenburg AG. Prospective randomized trial of emergency portacaval shunt and medical therapy in unselected cirrhotic patients with bleeding varices. Gastroenterology 1986; 90; 1754 (abstract).
Cello JP, Grendell JH, Crass RA, Weber TE, Trunkey DD. Endoscopic sclerotherapyversus portacaval shunt in patients with severe cirrhosis and acute variceal haemorrhage. Long term follow-up. N Engl J Med 1987; 316: 11–15.
Larson AW. Acute esophageal variceal sclerotherapy: results of a prospective randomized controlled trial. JAMA 1986; 255: 497.
Paquet KJ, Feussner H. Endoscopic sclerosis and oesophageal balloon tamponade in acute haemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology 1985; 5: 580–583.
Teres J, Baroni R, Bordas JM, Vias J, Pera C, Rodes J. Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding. J Hepathol 1987; 4: 159–167.
Huizinga WKJ, Angorn PA, Baker WW. Oesophageal transectionversus injection sclerotherapy in the management of bleeding oesophageal varices in patients at high risk. Surg Gyn Obstet 1985; 160: 539–546.
Reynolds TB, Donovan AJ, Mikkelsen WP, Redeker AG, Turrill FL, Weiner JM. Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleding varices. Gastroenterology 1981; 80: 1005.
Rueff B, Degos F, Degos JD, Maillard JN, Prandi D, Sicot C, Fauvert R, Benhamou JP. A controlled study of the therapeutic portocaval shunt in alcoholic cirrhosis. Lancet 1976; 1: 655.
Warren WD, Galambos JT, Riepe SP, Henderson JM, Scott Brooks W, Salam AA, Millikan WJ, Kunter MH. Distal splenorenal shuntversus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg 1986; 203: 454.
Jackson FC, Perrin EB, Felix WR, Smith AG. A clinical investigation on the portocaval shunt: survival analysis and therapeutic operation. Ann Surg 1971; 174: 672.
Pagliaro L, D'Amico GD, Tine' F, Pasta L, Malizia G, Vizzini G. Overview of prophylactic clinical trials (RCTs) for the prevention of bleeding in cirrhosis. Proceedings of “Surgery in Europe”-Roma-1987.
Stipa S, Ziparo V, Anza' M, Fabrini G, Lupino R. A randomized controlled trial of mesenterico-caval shunt with autologous jugular vein. Surg Gynecol Obstet 1981; 153: 353.
Bismuth H, Franco D, Hepp J. Portal-systemic shunt in hepatic cirrhosis: does the type of shunt decisively influence the clinical results? Ann Surg 1974; 179: 209.
Fulenwider JT, Nordlinger BM, Millikan WJ, Sones PJ, Warren WD. Portal perfusion: an angiographic illusion. Ann Surg 1979; 189: 257.
Stipa S, Ziparo V. Mesentericocaval shunt with autologous jugular vein. World J Surg 1984; 8: 702.
Conn HO, Resnick RH, Grace ND, Atterbury CE, Horst D, Grozman RJ, Gazmuri P, Gusberg RJ, Tahier B, Berk D, Wright SC, Vollman R, Tilson DM, Mc Dermott WV, Cohen JA, Kestein M, Toole AL, Maselli JP, Razvi S, Ishihara A, Stern H, Trey G, O'Hara ET, Wildrich W, Aisenberg M, Stansel HC, Zinny M. Distal splenorenal shuntversus portal-systemic shunt: current status of a controlled trial. Hepatology 1981; 1: 151–160.
Fischer JE, Bower RH, Atamian S, Welling R. Comparison of distal and proximal splenorenal shunts. A randomized prospective trial. Ann Surg 1981; 194: 531–544.
Millikan WJ Jr, Warren WD, Henderson JM, Smith RB 3rd, Salam AR, Galambos JT, Kutner MH, Keen JH. The Emory prospective randomized trial: selectiveversus nonselective shunt to control variceal bleeding. Ann Surg 1985; 201: 712–722.
Harley HAJ, Morgan T, Redeker AG, Reynolds TB, Villamil F, Weiner JM, Yellin A. Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology 1986; 91: 802–809.
Langer B, Taylor BR, Gilas T, Stone RM, Blendis L. Further report of prospective randomized trial comparing distal splenorenal shunt with end to side portacaval shunt. Gastroenterology 1985; 88: 424–429.
Reichle FA, Fahmy WF, Golsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg 1979; 137: 13–21.
Peracchia A. Non shunt treatment of esophageal varices. Proceedings of “Surgery in Europe”-Roma-1987.
Johnston GW. Oesophageal transection. Il Policlinico Sez Chir 1985; 92: 573–577.
Burroughs AK, Jenkins WJ, Sherlok S, Dunk A, Walt RP, Osvafor TO, Mackie S, Dick R. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539–1542.
Lebrec D, Poynard T, Bernuau J, Bercoff E, Nouel O, Capron JP, Poupon R, Bouvry M, Rueff B, Benhamou JP. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355.
Villeneuve JP, Pomier-Layrargues G, Infante-Rivard C, Willems B, Huet PM, Marleau D, Viallet A. Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial. Hepatology 1986; 6: 1239.
Terblanche J, Borman PC, Kahn D, Jonker MAT, Campbell JAH, Wright J, Kirsch R. Failure of repeated injection sclerotherapy to improve longterm survival after oesophageal variceal bleeding: a five year prospective controlled clinical trial. Lancet 1983; 2: 1328.
Westaby D, MacDougall BRD, Williams R. Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology 1985; 5: 827–830.
Copenhagen Esophageal Varices Sclerotherapy Project. Sclerotherapy after first variceal haemorrhage in cirrhosis. N Engl J Med 1984; 311: 1594–1600.
Warren WD, Galambos JT, Riepe SP, Henderson JM, Scott Brooks W, Salam AA, Millikan WJ, Kunter MH. Distal splenorenal shuntversus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg 1986; 203: 454.
Teres J, Bordas JM, Bravo D, Visa J, Grande L, Garcia-Valdegasas JC, Pera C, Rodes J. Sclerotherapy vs distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized, controlled trial. Hepatology 1987; 7: 430.
Rikkers LF, Burnett D, Volentine G, Buchi K, Cormier R. Shunt surgery vs endoscopic sclerotherapy for long-term treatment of variceal bleeding: early results of a randomized trial.
Child CG, Turcotte JG. Surgery and portal hypertension. In: The Liver and Portal Hypertension. Saunders Philadelphia, 1964; p. 51.
Stipa S, Thau A, Toscano M, Rossi P. Lo shunt mesenterico-cava con vena giugulare interna. Il Policlinico Sez Chir 1972; 77: 196.
Stipa S, Thau A, Schillaci A, Ziparo V, Rossi P, Passariello R. Mesenterico-caval shunt with internal jugular vein. Surg Gynecol Obstet 1978; 146: 391.
Voorhees AB Jr, Price JB, Britton RC. Porta-systemic shunting procedures for portal hypertension. Am J Surg 1970; 119: 501.
Author information
Authors and Affiliations
Additional information
This report is the gist of a paper read by S.S. at the 20th Annual Meeting of the Japanese Research Society for Portal Hypertension, Sendai, Japan, 1987
Rights and permissions
About this article
Cite this article
Stipa, S., Ziparo, V., Di Giulio, E. et al. Management of esophageal varices in the western world —The state of the art—. The Japanese Journal of Surgery 19, 131–142 (1989). https://doi.org/10.1007/BF02471577
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02471577